MedTrace Logo

SC2i Tissue and Data Repository Protocol

NCT02182180 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2025-09-04

No results posted yet for this study

Summary

The purpose of this study is to collect samples of blood, urine, cerebrospinal fluid (CSF, the fluid that surrounds the brain and spinal cord), wound tissue and/or wound fluids, and other body fluids and tissues from people who have been seriously injured or ill. The samples will be used to develop and assess tests and/or tools that doctors can use to decide the best treatment plan for seriously injured or ill military personnel and for civilians. Additonal protocols to use the samples will be submitted as separate protocols.

Conditions

  • Critical Illness

Sponsors & Collaborators

  • Uniformed Services University of the Health Sciences

    collaborator FED

  • United States Department of Defense

    collaborator FED

  • Duke University

    collaborator OTHER

  • Emory University

    collaborator OTHER

  • Grady Health System

    collaborator OTHER

  • Walter Reed National Military Medical Center

    collaborator FED

  • Henry M. Jackson Foundation for the Advancement of Military Medicine

    lead OTHER

Principal Investigators

  • CAPT Eric Elster, MD, US Navy · Uniformed Services University of the Health Sciences

  • Allan M. Kirk, MD, PhD · Duke University

  • Timothy G Buchman, Ph.D, MD · Emory University

  • Christopher J. Dente, MD · Grady Hospital

  • Benjamin K Potter, MD, FACS · Uniformed Services University - Walter Reed Surgery

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-09-09
Primary Completion
2027-08-31
Completion
2027-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02182180 on ClinicalTrials.gov